Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyridine nucleotide-disulphide oxidoreductase domain 1 pseudogene (ENSG00000213252, also called LOC100422300) is classified as a *pseudogene* in the human genome. This means it is a non-functional genomic element related by sequence to the functional **PYROXD1** gene, which encodes a pyridine nucleotide-disulphide oxidoreductase enzyme. Unlike the functional gene or protein, the pseudogene does **not** produce a protein product and lacks known molecular functions, disease associations, or drug interactions. It can sometimes be misidentified as a target due to confusion with the active PYROXD1 gene, which is genuinely associated with specific myopathies, but these functions do not apply to the pseudogene[5][1][3]. If you are seeking information on the **functional protein target**, refer to "Pyridine nucleotide-disulphide oxidoreductase domain 1" (PYROXD1), not its pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyridine nucleotide-disulphide oxidoreductase domain 1 pseudogene.